On this episode of Stock Movers:
- Expedia (EXPE) rises after the online travel agency’s results pointed to strong and resilient travel demand. Peer Airbnb (ABNB) also rallies after the company gave a better-than-expected outlook for the holiday quarter.
- Airbnb Inc. (ABNB) rises after issuing a better-than-expected outlook for the holiday quarter, with a recently launched “reserve now, pay later” feature helping fuel demand in the US.
- Sweetgreen (SG) falls after the restaurant chain cut its revenue guidance for the full year, missing the average analyst estimate. William Blair downgrades its rating on the stock.

On this episode of Stock Movers: - Expedia (EXPE) rises after the online travel agency&rsquo;s results pointed to strong and resilient travel demand. Peer Airbnb (ABNB) also rallies after the company gave a better-than-expected outlook for the holiday quarter. - Airbnb Inc. (ABNB) rises after issuing a better-than-expected outlook for the holiday quarter, with a recently launched &ldquo;reserve now, pay later&rdquo; feature helping fuel demand in the US. - Sweetgreen (SG) falls after the restaurant chain cut its revenue guidance for the full year, missing the average analyst estimate. William Blair downgrades its rating on the stock.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Expedia Rises, Airbnb Gains, Sweetgreen Falls After Rating Downgrade

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/55140b0b-f223-487f-ae84-b38e00fcf5be/transcript

On this episode of Stock Movers:
- Novo Nordisk (NVO) won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly. The shares soared by as much as 11% in Copenhagen, the biggest intraday gain since August. Novo has fallen by almost half this year amid concern about the Danish drugmaker’s ability to compete in the obesity market it pioneered. Shares continued to rally in New York trading on Tuesday.
- Johnson & Johnson (JNJ) was ordered to pay about $1.56 billion to a Maryland woman who blamed the company’s talc-based baby powder for causing her asbestos-linked cancer, the largest such verdict for an individual in 15 years of litigation. The verdict comes as J&J has been pummeled by a recent spate of baby powder verdicts after it failed this year to use bankruptcy court to force a settlement of more than 70,000 lawsuits accusing the company of hiding the product’s cancer risks. Shares of the company fell in trading on Tuesday.
- ServiceNow (NOW) has reached a deal to buy the cybersecurity startup Armis in a deal valued at $7.75 billion, representing its largest acquisition to date. Shares in ServiceNow fell about 1.3% in early trading before markets opened in New York. They closed up around 0.9% on Monday, giving the company a market valuation of about $163 billion.

On this episode of Stock Movers: - Novo Nordisk (NVO) won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly. The shares soared by as much as 11% in Copenhagen, the biggest intraday gain since August. Novo has fallen by almost half this year amid concern about the Danish drugmaker&rsquo;s ability to compete in the obesity market it pioneered. Shares continued to rally in New York trading on Tuesday. - Johnson &amp; Johnson (JNJ) was ordered to pay about $1.56 billion to a Maryland woman who blamed the company&rsquo;s talc-based baby powder for causing her asbestos-linked cancer, the largest such verdict for an individual in 15 years of litigation. The verdict comes as J&amp;J has been pummeled by a recent spate of baby powder verdicts after it failed this year to use bankruptcy court to force a settlement of more than 70,000 lawsuits accusing the company of hiding the product&rsquo;s cancer risks. Shares of the company fell in trading on Tuesday. - ServiceNow (NOW) has reached a deal to buy the cybersecurity startup Armis in a deal valued at $7.75 billion, representing its largest acquisition to date. Shares in ServiceNow fell about 1.3% in early trading before markets opened in New York. They closed up around 0.9% on Monday, giving the company a market valuation of about $163 billion.

Novo Nordisk Rallies, Johnson & Johnson Slides, ServiceNow Falls

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/13b7eead-2540-41ee-b2c9-b3bc0150918f/transcript

On this episode of Stock Movers:
- Novo Nordisk (NOVOB) won approval to sell a pill version of its obesity shot Wegovy in the US, to help people lose weight or maintain previous weight loss over the long term. The company will start selling the pill in the US in early January, and it is approved based on the results of the Oasis 4 trial, which found people taking the pill lost about 13.6% of their body weight over 64 weeks.
- Johnson & Johnson (JNJ) was ordered to pay about $1.56 billion to a Maryland woman who blamed the company's talc-based baby powder for causing her asbestos-linked cancer.
- ServiceNow Inc. has reached a deal to buy the cybersecurity startup Armis in a deal valued at $7.75 billion, representing its largest acquisition to date. Shares have fallen over 4% on the news.

On this episode of Stock Movers: - Novo Nordisk (NOVOB) won approval to sell a pill version of its obesity shot Wegovy in the US, to help people lose weight or maintain previous weight loss over the long term. The company will start selling the pill in the US in early January, and it is approved based on the results of the Oasis 4 trial, which found people taking the pill lost about 13.6% of their body weight over 64 weeks. - Johnson &amp; Johnson (JNJ) was ordered to pay about $1.56 billion to a Maryland woman who blamed the company's talc-based baby powder for causing her asbestos-linked cancer. - ServiceNow Inc. has reached a deal to buy the cybersecurity startup Armis in a deal valued at $7.75 billion, representing its largest acquisition to date. Shares have fallen over 4% on the news.

Novo Nordisk Soars, Johnson & Johnson Drops, ServiceNow Falls

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/8f07f33f-8d50-4691-9d7e-b3bc010aca7a/transcript

On this episode of Stock Movers:
- Novo Nordisk (NOVOB) won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly (LLY). The shares soared by as much as 11% in Copenhagen, the biggest intraday gain since August. Novo has fallen by almost half this year amid concern about the Danish drugmaker’s ability to compete in the obesity market it pioneered.
- Copper hit a fresh all-time high above $12,000 a ton due to severe mine outages and trade dislocations linked to US President Donald Trump’s tariff agenda. Shares of Albemarle climbed as a result. 
- The US Navy announced plans to build a new class of warship, the FF(X), as part of President Donald Trump's "Golden Fleet" bid to revive US shipbuilding. That caused shares of Huntington Ingalls Industries Inc. to rise.

On this episode of Stock Movers: - Novo Nordisk (NOVOB) won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly (LLY). The shares soared by as much as 11% in Copenhagen, the biggest intraday gain since August. Novo has fallen by almost half this year amid concern about the Danish drugmaker&rsquo;s ability to compete in the obesity market it pioneered. - Copper hit a fresh all-time high above $12,000 a ton due to severe mine outages and trade dislocations linked to US President Donald Trump&rsquo;s tariff agenda. Shares of Albemarle climbed as a result. - The US Navy announced plans to build a new class of warship, the FF(X), as part of President Donald Trump's "Golden Fleet" bid to revive US shipbuilding. That caused shares of Huntington Ingalls Industries Inc. to rise.

Novo Nordisk Soars, Albermarle Climbs , Huntington Ingall Rises

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/4285abed-5aab-4f9b-b881-b3bc00ffabe9/transcript

Expedia Rises, Airbnb Gains, Sweetgreen Falls After Rating Downgrade

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips